PULSE BIOSCIENCES, INC. 8-K
Research Summary
AI-generated summary
Pulse Biosciences to Redeem Rights-Offering Warrants
What Happened
Pulse Biosciences, Inc. (PLSE) announced on June 10, 2026 that it will deliver an irrevocable election to redeem the remaining common stock warrants issued in its July 3, 2024 rights offering. The company set a redemption (and final exercise) date of July 13, 2026; any affected warrants not exercised by 5:00 p.m. ET on that date will be redeemed for $0.01 per warrant share.
Key Details
- Warrants involved: the remaining "200% Warrants" from the rights offering (CUSIP #74587B143).
- Exercise terms: holders may exercise the warrants for cash at any time before 5:00 p.m. ET on July 13, 2026.
- Redemption price: $0.01 per underlying share for any warrants not exercised.
- Trigger condition described in the warrant: redemption permitted if the company’s VWAP equals or exceeds 200% of the warrant exercise price (i.e., $22.00, implying an exercise price of $11.00) for 20 consecutive trading days; the company is now delivering the irrevocable election to redeem.
Why It Matters
For warrant holders: you have until July 13, 2026 to decide whether to exercise for cash; otherwise your warrants will be redeemed for $0.01 each, essentially eliminating any remaining claim. For common shareholders and potential investors: successful redemption will remove these warrants from the cap table and eliminate a potential source of future dilution (but will not generate material cash proceeds unless warrants are exercised). Monitor the company’s share price and any investor communications ahead of the July 13 deadline.
Loading document...